DCLK1 and ovarian cancer: In ovarian cancer, miR-424 can act as a tumor suppressor by inhibiting cell migration, invasion, and EMT via down-regulating the expression of doublecortin-like kinase 1 (DCLK1) and MYB (99, 100).